SVA stock is undervalued, Research Capital says

A management shuffle at Sernova Corp isn’t dampening analyst Andre Uddin’s enthusiasm for the stock..

Related Keywords

,Brett Whalen ,Cynthia Pussinen ,Andre Uddin ,Philip Toleikis ,Ipsen Biosciences ,Ipsen Biomeasure ,Spark Therapeutics Inc ,Sernova Corp Stock ,Roche Group ,Nasdaq ,Technology Officer ,Sernova Corp ,Sernova Corp Stock Quote ,Chief Technology ,Chief Executive Officer ,Chief Technology Officer ,Chief Technical Officer ,Spark Therapeutics ,